These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 643153)

  • 1. [Cerebrospinal fluid amine metabolites and L-dopa in vegetative state patients (author's transl)].
    Inagawa T; Ishikawa S; Uozumi T
    No Shinkei Geka; 1978 Mar; 6(3):235-43. PubMed ID: 643153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in the patients with epilepsy (author's transl)].
    Nagao T; Fujimoto A; Ohshimo T; Yamamoto M; Kugoh T; Akiyama K; Otsuki S
    No To Shinkei; 1979 Dec; 31(12):1225-31. PubMed ID: 93481
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
    Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Homovanillic acid and 5--hydroxy-indoleacetic acid in the cerebrospinal fluid of man--concentration gradients between lumbar and ventricular CSF and variations in ventricular CSF-- (author's transl)].
    Inagawa T; Kajihara S; Okada Y; Yoshimoto H; Mori S; Ishikawa S; Uozumi T
    No To Shinkei; 1978 May; 30(5):565-74. PubMed ID: 666924
    [No Abstract]   [Full Text] [Related]  

  • 5. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid of patients with acute cerebrovascular lesion.
    Livrea P; Papagno G; Di Reda L; Centrone G
    Acta Neurol (Napoli); 1976; 31(5):647-51. PubMed ID: 1015387
    [No Abstract]   [Full Text] [Related]  

  • 6. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
    Yamamoto M
    Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
    [No Abstract]   [Full Text] [Related]  

  • 7. Parallel variation of homovanillic acid and 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid of man.
    Inagawa T; Mori S; Yoshimoto H; Ishikawa S; Uozumi T
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):79-87. PubMed ID: 1026667
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
    Buckingham RL; Radulovacki M
    Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 10. [5-HIAA and HVA levels in the cerebrospinal fluid of hydrocephalic patients].
    Massarotti M; Migliore A; Roccella P; Toffano G
    Acta Neurol (Napoli); 1976; 31(5):601-13. PubMed ID: 1015383
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
    Willemse J; van Nieuwenhuizen O; Gooskens RH; Westenberg HG
    Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
    Campanella G; Algeri S; Cerletti C; Dolfini E; Jori A; Rinaldi F
    Eur J Clin Pharmacol; 1977 Apr; 11(4):255-61. PubMed ID: 862646
    [No Abstract]   [Full Text] [Related]  

  • 13. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
    Livrea P; Di Reda L; Puca FM; Genco S; Specchio L; Papagno G
    Boll Soc Ital Biol Sper; 1976 Jun; 52(11):800-5. PubMed ID: 1016632
    [No Abstract]   [Full Text] [Related]  

  • 14. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 15. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J; Sharpe D; Curzon G
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract]   [Full Text] [Related]  

  • 16. Gradients of biogenic amine metabolites in cerebrospinal fluid.
    Siever L; Kraemer H; Sack R; Angwin P; Berger P; Zarcone V; Barchas J; Brodie HK
    Dis Nerv Syst; 1975 Jan; 36(1):13-6. PubMed ID: 1109880
    [No Abstract]   [Full Text] [Related]  

  • 17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE; Foxx JL; Butler IJ
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

  • 19. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
    Fukuyama Y; Ochiai Y; Hayakawa T; Miyagawa F
    Neuropadiatrie; 1979 May; 10(2):138-49. PubMed ID: 226908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.